UNSPSC 51473005: Benzododecinium

This classification denotes a topical anti-infective agent with the molecular formula C21H38N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N0BN0O8CSL, chemically known as n-dodecyl-n, n-dimethylbenzenemethanaminium chloride but generally known as benzododecinium, which bears US NIH Compound Identifier 8754. Benzododecinium most often comes in base, bromatum, bromide, and chloride forms. European Medicines Agency schedules Benzododecinium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00724MIG.

UNSPSC 51473005 Benzododecinium is a Commodity code encompassing quaternary ammonium compounds and similar antimicrobial and disinfectant agents purchased by state and local governments for janitorial, operational, and healthcare facility applications. State and local issuing bodies procure benzododecinium products as consumable supplies for fire rescue departments, public safety facilities, healthcare systems, and multi-agency cooperative purchasing vehicles. The work involves supplying new, unused products in original packaging to government facilities on an as-needed or term-contract basis, with vendors required to hold authorized distributor status, maintain backorder and recall capabilities, and meet delivery windows ranging from five to ten business days depending on urgency.

Recent activity shows issuing bodies concentrated in county governments and multistate cooperative purchasing alliances. Hillsborough County Board of County Commissioners issued an ITB for janitorial and operational supplies (ITB2600319) due July 24, 2026, with an estimated one-year contract value of $765,679.84 for delivery to the Hillsborough County Fire Rescue Department across 47 fire stations in the Tampa, Florida area. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP (S1070000015802) for generic multi-source pharmaceuticals and OTC products with a March 26, 2026 proposal deadline, establishing contracts for distribution across participating state and local government facilities including Oregon. The MMCAP procurement requires vendors to certify compliance with current Good Manufacturing Practices and the Drug Supply Chain Security Act, maintain relationships with authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., LLC), and accept a 3 percent administrative fee on all contract purchases. Recent opportunities reflect activity in Florida and multistate cooperative purchasing covering the upper Midwest and Pacific Northwest.